Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Consolidated Balance Sheets (Unaudited)

v3.21.2
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Current assets    
Cash and cash equivalents $ 332,871 $ 272,092
Short-term deposits 187,000 27,000
Accounts receivable, net of allowance for credit losses of $0.7 million and $0.9 million as of September 30, 2021 and December 31, 2020 121,848 106,068
Inventories 119,925 131,672
Prepaid expenses 8,634 6,717
Other current assets 27,317 16,943
Total current assets 797,595 560,492
Non-current assets    
Property, plant and equipment, net 199,668 201,232
Goodwill 39,750 35,694
Other intangible assets, net 117,010 131,569
Operating lease right-of-use assets 15,624 21,298
Other non-current assets 58,365 39,717
Total non-current assets 430,417 429,510
Total assets 1,228,012 990,002
Current liabilities    
Accounts payable 48,292 16,987
Accrued expenses and other current liabilities 30,875 31,061
Accrued compensation and related benefits 36,983 25,659
Deferred revenues - short term 49,104 49,165
Operating lease liabilities - short term 7,514 9,282
Total current liabilities 172,768 132,154
Non-current liabilities    
Deferred revenues - long term 17,980 14,227
Operating lease liabilities - long term 8,353 12,567
Contingent consideration 40,589 37,400
Other non-current liabilities 37,869 34,059
Total non-current liabilities 104,791 98,253
Total liabilities 277,559 230,407
Contingencies (see note 12)
Redeemable non-controlling interests   227
Equity    
Ordinary shares, NIS 0.01 nominal value, authorized 180,000 thousand shares; 65,467 thousand shares and 56,617 thousand shares issued and outstanding at September 30, 2021 and December 31, 2020, respectively 182 155
Additional paid-in capital 3,001,685 2,753,955
Accumulated other comprehensive loss (8,372) (8,846)
Accumulated deficit (2,043,042) (1,985,896)
Total equity 950,453 759,368
Total liabilities and equity $ 1,228,012 $ 990,002